XML 19 R5.htm IDEA: XBRL DOCUMENT v3.24.0.1
Consolidated Statements of Comprehensive Loss - USD ($)
shares in Thousands, $ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Revenues [Abstract]      
Revenues $ 331,412 $ 270,827 $ 157,170
Expenses:      
Cost of product sales 4,481 6,408 7,229
Research and development 216,566 253,297 208,808
Selling, general and administrative 213,894 159,371 118,818
Royalty 180 186 35
Total operating expenses 435,121 419,262 334,890
Loss from operations (103,709) (148,435) (177,720)
Interest and other income 15,777 5,127 62
Interest expense (108,239) (99,092) (59,294)
(Loss) gain on extinguishment of debt (29,019) 0 55,838
Foreign currency losses, net (1,039) (1,983) (695)
Loss before income taxes (226,229) (244,383) (181,809)
Income tax expense 310 2,733 2,253
Net loss (226,539) (247,116) (184,062)
Foreign currency translation adjustment 180 890 189
Unrealized gain (loss) on available for sale investments 1,131 (1,041) (15)
Net comprehensive loss $ (225,228) $ (247,267) $ (183,888)
Earnings per share, basic (in usd per share) $ (1.18) $ (1.33) $ (1.03)
Earnings per share, diluted (in usd per share) $ (1.18) $ (1.33) $ (1.03)
Weighted average shares outstanding, basic (in shares) 192,198 185,908 179,117
Weighted average shares outstanding, diluted (in shares) 192,198 185,908 179,117